Cyclin A1 is predominantly expressed in hematological malignancies with myeloid differentiation

被引：0
作者：
Krämer, R [1 ]
Hochhaus, A [1 ]
Saussele, S [1 ]
Reichert, A [1 ]
Willer, A [1 ]
Hehlmann, R [1 ]
机构：
[1] Univ Heidelberg, Klinikum Mannheim, Med Klin 3, Mannheim, Germany
来源：
BRITISH JOURNAL OF HAEMATOLOGY | 1998年 / 102卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：30 / 30
页数：1
相关论文
共 50 条
  • [21] A group of previously not recognized cytogenetic abnormalities in myeloid hematological malignancies
    Chen, Z
    Richkind, K
    Roherty, S
    Velasco, J
    Lytle, C
    Brothman, AR
    Sandberg, AA
    CANCER GENETICS AND CYTOGENETICS, 1999, 113 (02) : 162 - 165
  • [22] Differentiation therapy for myeloid malignancies: beyond cytotoxicity
    Stubbins, Ryan J.
    Karsan, Aly
    BLOOD CANCER JOURNAL, 2021, 11 (12)
  • [23] Differentiation therapy for myeloid malignancies: beyond cytotoxicity
    Ryan J. Stubbins
    Aly Karsan
    Blood Cancer Journal, 11
  • [24] c-myb transactivates the human cyclin A1 promoter and induces cyclin A1 gene expression
    Müller, C
    Yang, R
    Idos, G
    Tidow, N
    Diederichs, S
    Koch, OM
    Verbeek, W
    Bender, TP
    Koeffler, HP
    BLOOD, 1999, 94 (12) : 4255 - 4262
  • [25] MUC1 in hematological malignancies
    Stroopinsky, Dina
    Kufe, Donald
    Avigan, David
    LEUKEMIA & LYMPHOMA, 2016, 57 (11) : 2489 - 2498
  • [26] MYELOID DIFFERENTIATION ANTIGENS EXPRESSED BY ANL CELLS
    DINNDORF, P
    ANDREWS, R
    HARTMANN, J
    BERNSTEIN, I
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1983, 24 (MAR): : 204 - 204
  • [27] Myeloid-derived suppressor cells in hematological malignancies: friends or foes
    Meng Lv
    Ke Wang
    Xiao-jun Huang
    Journal of Hematology & Oncology, 12
  • [28] Serologic Responses to COVID-19 Vaccines in Hematological Patients Are Predominantly Impaired in Lymphoid but not in Myeloid Malignancies (vol 6, e686, 2022)
    Petzer, Verena
    Steiner, Normann
    Angelova-Unterberger, Olga
    Hetzenauer, Gabriele
    Philipp-Abbrederis, Kathrin
    Willenbacher, Ella
    Feistritzer, Clemens
    Willenbacher, Wolfgang
    Rudzki, Jakob
    Stauder, Reinhard
    Kocher, Florian
    Seeber, Andreas
    Pircher, Andreas
    Tymoszuk, Piotr
    Isara, Christian
    Egger, Alexander
    Fux, Vilmos
    Anliker, Markus
    Gunsilius, Eberhard
    Nachbaur, David
    Schmidt, Stefan
    Wolf, Dominik
    HEMASPHERE, 2022, 6 (06):
  • [29] Myeloid-derived suppressor cells as therapeutic target in hematological malignancies
    De Veirman, Kim
    Van Valckenborgh, Els
    Lahmar, Qods
    Geeraerts, Xenia
    De Bruyne, Elke
    Menu, Eline
    Van Riet, Ivan
    Vanderkerken, Karin
    Van Ginderachter, Jo A.
    FRONTIERS IN ONCOLOGY, 2014, 4
  • [30] Myeloid-derived suppressor cells in hematological malignancies: friends or foes
    Lv, Meng
    Wang, Ke
    Huang, Xiao-jun
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2019, 12 (01)
12345